This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmacology is one of the most fundamental aspects of medication therapy. 1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? Due to limited knowledge of pharmacology, the sales rep failed to properly communicate and was unable to address the physicians concerns.
The current medications (opioid and non-opioid) often force the patients to make an unfortunate choice between efficacy and debilitating sideeffects, leading to a cycling through multiple different therapies and suboptimal treatment response. Towards the end of 2023, one sensed an emerging interest from Big Pharma in neuroscience.
In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal sideeffects. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex.
Unveiling the Role of a Pharma Sales Rep Pharmaceutical sales representatives (PSRs) play a pivotal role in driving sales for their company’s pharmaceutical products. PSRs must possess a robust understanding of pharmacology, adeptly navigating inquiries on drug mechanisms, sideeffects, and interactions.
The main label contains data that is generally in a semi-structured format, with sections covering: description of the drug, clinical pharmacology, indications (uses for the drug), contraindications (who should not take the drug), warnings and precautions, and adverse events (sideeffects).
During my pharmacology class, I learned that there are no safe drugs, only safe patients. This includes potential sideeffects or adverse reactions to medications. This is why generic drugs may have slightly different sideeffects or efficacy profiles compared to their brand-name counterparts.
3 Managing SideEffects : Balancing drug exposure and effect to achieve desired outcomes. This is especially critical in oncology, where chemotherapeutic agents require precise dosing to improve survival while minimizing sideeffects. Rang & Dale’s Pharmacology. metformin). link] Rang, H.
Pharmaceutical representatives (pharma reps) are facing new challenges as a result of these transformations that have drastically altered the pharmaceutical sales landscape. Essential Competencies in Pharmaceutical Sales First, let’s review the competencies of a successful sales rep in pharma.
Pharmaceutical sales representatives (commonly known as “pharma reps” or “drug reps”) are responsible for promoting and educating healthcare providers about their company’s products, with the ultimate goal of increasing product sales and market share.
After more than a decade in development, Freya Pharma Solutions plans to advance an oral tablet dubbed Lybrido into Phase III trials to treat female sexual interest/arousal disorder (FSIAD). Overall, sideeffects serve as a more significant barrier in this condition than elsewhere because the condition is not life-threatening, says Ben-Zion.
The agency proposes that pharma move away from the common maximum tolerated dose (MTD) to trial designs that prioritise drug dosage optimisation at different stages. The demand came amid concerns that the drug causes a slew of sideeffects such as nausea, diarrhea, and liver issues.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content